Related Experiment Video
Updated: Aug 6, 2026

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
Published on: July 28, 2010
[Fundamental aspects: mechanisms of carcinogenesis and dose-effect relationship]
1Laboratoire de génétique oncologique, UMR 1599 CNRS, Institut Gustave-Roussy, Villejuif, France. froyer@igr.fr
Abstract:
Oncogenesis is a multistep process, which is the outcome of the accumulation in a single cell of genetic and epigenetic events. The events alter proto-oncogenes, which are converted into oncogenes with gain of function and tumor suppressor genes with loss of function. Cellular mechanisms (e.g. apoptosis) protect tissues against the malignant transformation of cells and limit, for each tissue, the combinations of efficient genetic alterations. The number of genetic events required for conversion to malignancy is still debated, but, at least in the case of many solid tumors (e.g. colon carcinomas), this number may be as high as seven to eight, which implies that a genetic instability occurs during cancer progression. In most cancers the probability of occurrence of oncogenic genetic events is increased by exposure to behavioural and environmental factors. In the case of chemical carcinogens, the dose-effect relationship is strongly affected by their effects on cellular proliferation, which should be taken account into when the experimental data of animal experiments are extrapolated to human exposures. When non-genotoxic carcinogens are considered, a threshold in the dose-effect relationship is generally observed. For genotoxic carcinogens, it is hard to prove experimentally that a threshold exists and linear no-threshold relationships are generally used to evaluate permissible levels of human exposures.
Insights
Cancer development (oncogenesis) involves accumulating genetic and epigenetic changes. Environmental factors and carcinogen exposure influence these events, impacting cancer risk and risk assessment strategies.
Area of Science:
- Oncology
- Genetics
- Environmental Health
Context:
- Oncogenesis is a multistep process driven by genetic and epigenetic alterations in a single cell.
- Proto-oncogenes gain function (oncogenes), while tumor suppressor genes lose function.
- Cellular mechanisms like apoptosis prevent malignant transformation, but genetic instability is crucial for cancer progression.
Purpose:
- To elucidate the multistep nature of oncogenesis.
- To explain the roles of genetic/epigenetic events, oncogenes, and tumor suppressor genes.
- To discuss the influence of environmental factors and carcinogens on cancer development.
Summary:
- Cancer arises from accumulated genetic and epigenetic events, altering key genes.
- Multiple genetic events, potentially up to seven or eight for solid tumors, are implicated.
- Behavioral and environmental factors, including chemical carcinogens, increase oncogenic event probability.
Impact:
- Understanding oncogenesis is vital for cancer prevention and treatment strategies.
- Dose-effect relationships for carcinogens inform risk assessment and regulatory policies.
- Distinguishing between genotoxic and non-genotoxic carcinogens is critical for human exposure guidelines.
More Related Videos
09:33Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
04:12Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)
Published on: December 19, 2019
Related Concept Videos
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Prevention
Some...
Mutagenicity and Carcinogenicity
Dose-Response Relationship: Overview
Pharmacokinetic–Pharmacodynamic Relationship: Intensity of Dose-Effect Relationship